Enhanced gene expression in the brain following intravenous administration of lactoferrin-bearing polypropylenimine dendriplex

The possibility of using gene therapy for the treatment of brain diseases such as brain cancer, Alzheimer's and Parkinson's diseases, is currently hampered by the lack of gene delivery systems able to cross the blood–brain barrier and deliver DNA to the brain following intravenous administration.